/ March 29, 2018/ News and Events

Chemical and Engineering News featured the proprietary RiMO technology for its ability to generate two types of tumor-fighting reactive oxygen species with deeply penetrating X-rays and to activate T cells to attack tumor tissue systemically.

Share this Post